MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
Aug 15, 04:59 PM (EDT)
Price
$52.41
Change
+$1.46 (+2.87%)
Capitalization
226.58B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVO with price predictions
Aug 14, 2025

NVO in -2.54% downward trend, declining for three consecutive days on August 12, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NVO declined for three days, in of 274 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

NVO moved below its 50-day moving average on July 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for NVO entered a downward trend on July 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVO's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on NVO as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NVO just turned positive on August 14, 2025. Looking at past instances where NVO's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.606) is normal, around the industry mean (8.904). P/E Ratio (13.052) is within average values for comparable stocks, (23.460). Projected Growth (PEG Ratio) (1.476) is also within normal values, averaging (1.835). Dividend Yield (0.032) settles around the average of (0.028) among similar stocks. P/S Ratio (4.649) is also within normal values, averaging (3.346).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVO is expected to report earnings to rise 3.12% to 95 cents per share on November 05

Novo-Nordisk A/S NVO Stock Earnings Reports
Q3'25
Est.
$0.96
Q2'25
Est.
$0.93
Q1'25
Beat
by $5.64
Q4'24
Beat
by $5.46
Q3'24
Beat
by $5.24
The last earnings report on August 06 showed earnings per share of 92 cents, missing the estimate of 93 cents. With 6.91M shares outstanding, the current market capitalization sits at 226.58B.
A.I.Advisor
published Dividends

NVO paid dividends on April 08, 2025

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $1.10 per share was paid with a record date of April 08, 2025, and an ex-dividend date of March 31, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IQDG38.97-0.02
-0.05%
WisdomTree International Qual Div Gr ETF
BRHY51.74-0.05
-0.09%
iShares High Yield Active ETF
CORN16.77-0.03
-0.18%
Teucrium Corn Fund
DVY138.75-0.57
-0.41%
iShares Select Dividend ETF
DBP76.37-0.56
-0.73%
Invesco DB Precious Metals

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+0.10%
NONOF - NVO
70%
Closely correlated
+0.38%
TECH - NVO
36%
Loosely correlated
-1.77%
GMAB - NVO
35%
Loosely correlated
+1.37%
BCAB - NVO
33%
Loosely correlated
-7.21%
MRK - NVO
32%
Poorly correlated
+0.06%
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+0.10%
Pharmaceuticals: Major
industry (61 stocks)
40%
Loosely correlated
+0.49%
Pharmaceuticals
industry (393 stocks)
31%
Poorly correlated
-0.29%